Literature DB >> 29524036

Ankylosing spondylitis monocyte-derived macrophages express increased level of A2A adenosine receptor and decreased level of ectonucleoside triphosphate diphosphohydrolase-1 (CD39), A1 and A2B adenosine receptors.

Maryam Akhtari1, Seyed Jalal Zargar2, Mahdi Mahmoudi3, Mahdi Vojdanian3, Alireza Rezaeimanesh4, Ahmadreza Jamshidi5.   

Abstract

Macrophages play an important role in the ankylosing spondylitis (AS) auto-inflammatory responses and fibrocartilage destruction. Adenosine is a key modulator of inflammatory conditions. The various effects of adenosine are mediated by its interaction with adenosine receptors (AR). In this study, we investigated the mRNA expression of A1, A2A, A2B, and A3 adenosine receptors, ectonucleoside triphosphate diphosphohydrolase-1 (CD39), and ecto-5'-nucleotidase (CD73) in the monocyte-derived macrophages from AS patients in comparison to healthy controls. We also explored the correlation between analyzed gene expression and patients' clinical manifestations. Whole blood-separated monocytes from 23 healthy controls and 23 active AS patients were stimulated by macrophage colony-stimulating factor (M-CSF) for 7 days and differentiated to macrophages. Monocyte and macrophage markers were analyzed by flow cytometry. Analysis of adenosine receptors (ADORA1، ADORA2A، ADORA2B، ADORA3), CD39 and CD73 gene expression was performed by SYBR green real-time PCR. Our results demonstrated monocyte-derived macrophages from AS patients expressed increased level of A2AAR and reduced level of A1, A2BAR, and CD39 mRNA compared to healthy controls. We found an inverse correlation between A2AAR mRNA expression and Bath Ankylosing Spondylitis Functional Index (BASFI) score in AS patients. According to our results, altered expression level of adenosine-relying system would be involved in AS macrophage dysfunction and inflammation and correlated with functional status in AS patients.

Entities:  

Keywords:  Adenosine receptors; Ankylosing spondylitis; Ectonucleoside triphosphate diphosphohydrolase-1 (CD39); Macrophages

Mesh:

Substances:

Year:  2018        PMID: 29524036     DOI: 10.1007/s10067-018-4055-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  42 in total

1.  Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms.

Authors:  G Haskó; D G Kuhel; J F Chen; M A Schwarzschild; E A Deitch; J G Mabley; A Marton; C Szabó
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

2.  Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.

Authors:  Laura M Kreckler; Tina C Wan; Zhi-Dong Ge; John A Auchampach
Journal:  J Pharmacol Exp Ther       Date:  2005-12-09       Impact factor: 4.030

Review 3.  Ankylosing spondylitis and bowel disease.

Authors:  Martin Rudwaleit; Dominique Baeten
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.

Authors:  Sekhar Majumdar; Bharat B Aggarwal
Journal:  Oncogene       Date:  2003-02-27       Impact factor: 9.867

6.  The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages.

Authors:  A Buenestado; S Grassin Delyle; I Arnould; F Besnard; E Naline; S Blouquit-Laye; A Chapelier; J F Bellamy; P Devillier
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

Review 7.  Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

Authors:  Lode Melis; Dirk Elewaut
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

Review 8.  Adenosine, an endogenous distress signal, modulates tissue damage and repair.

Authors:  B B Fredholm
Journal:  Cell Death Differ       Date:  2007-03-30       Impact factor: 15.828

Review 9.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

10.  Inhibition of human monocyte TNF production by adenosine receptor agonists.

Authors:  V Le Vraux; Y L Chen; I Masson; M De Sousa; J P Giroud; I Florentin; L Chauvelot-Moachon
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

View more
  4 in total

Review 1.  Expression and Metabolomic Profiling in Axial Spondyloarthritis.

Authors:  Darren D O'Rielly; Guangju Zhai; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2018-06-27       Impact factor: 4.592

Review 2.  The role of adenosine A1 receptor on immune cells.

Authors:  Lingyu Zhong; Qiao Peng; Xun Zeng
Journal:  Inflamm Res       Date:  2022-09-05       Impact factor: 6.986

3.  The serum uric acid is longitudinally related to patients global assessment of disease activity in male patients with axial spondyloarthritis.

Authors:  Meimei Cai; Wen Liu; Yuanhui Wu; Qing Zheng; Dehao Liu; Guixiu Shi
Journal:  BMC Musculoskelet Disord       Date:  2022-07-27       Impact factor: 2.562

4.  A2A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients.

Authors:  Omid Sadatpour; Mohammad Taha Ebrahimi; Maryam Akhtari; Nooshin Ahmadzadeh; Mahdi Vojdanian; Ahmadreza Jamshidi; Elham Farhadi; Mahdi Mahmoudi
Journal:  BMC Musculoskelet Disord       Date:  2022-10-12       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.